SL

Spiros Liras

Venture partner at Apple Tree Partners

Brookline, Massachusetts

Invests in

Stages:

Sectors:

Pharmaceuticals

Health & Hospital Services

Locations:

Min Investment:
$100,000.00
Max Investment:
$5,000,000.00
Target Investment:
$1,500,000.00

Skills

Early Stage Investment

Start-up Ventures

Venture Management

Drug Development

Drug Design

Medicinal Chemistry

Organic Chemistry

Drug Discovery

Pharmaceutical Industry

Education

Postdoctoral research
The University of Texas at Austin
Doctor of Philosophy (PhD)
Iowa State University
Bachelor of Science - BS
St. Ambrose University

Investments

Deep Apple Therapeutics

Total Funding: $52M

Initial Therapeutics

Total Funding: $75M

Nereid Therapeutics

Total Funding: $50M

Work Experience

ATP (Apple Tree Partners)

2019

Deep Apple Therapeutics; Co-Founder, CEO and Board Director
2021
Nereid Therapeutics; Co-Founder, founding CEO, Board Director
2020
Intitial Therapeutics; Co-Founder, CEO and Board Director
2020
Nine Square Therapeutics; Co-Founder, Founding CEO and Board Director
2020
Venture Partner
2019

University of California, San Francisco, Department of Pharmaceutical Chemistry

2019

Adjunct Full Professor
2019

2018 - 2019

Head, External Portfolio Innovation Unit
2018 - 2019

2009 - 2018

VP Medicinal Chemistry
2017 - 2018
VP, CVMED Medicinal Chemistry
2011 - 2017
Executive Director
2009 - 2011
Head of CVMED medicinal chemistry

1994 - 2008

Senior Director, Neuroscience medicinal chemistry
2004 - 2008
Medicinal chemist
1994 - 2004